Ketogenic nutrition and insulin-targeted metabolic psychiatry may add a new tool for severe mental illness.
Shebani Sethi, MD
Advertisement
Dr Sethi is a founding director of the flagship Stanford Metabolic Psychiatry Clinic, a clinical associate professor at Stanford University, and the founder of Metabolic Psychiatry Labs Inc, a digital health platform translating research on metabolism-based psychiatric care into accessible clinical applications.
Articles by Shebani Sethi, MD
Learn why ketogenic metabolic therapy is a monitored medical treatment, not a fad diet, and how metabolic pathways may reshape mental health care.
How insulin resistance, inflammation, and ketogenic therapy reshape treatment for bipolar and schizophrenia—inside the rise of metabolic psychiatry.
Learn more about effective strategies for managing obesity and metabolic dysfunction in schizophrenia, focusing on dietary interventions and pharmacological treatments.
Advertisement
Latest Updated Articles
From Side Effect to Target: Rethinking Metabolic Dysfunction in PsychiatrySeptember 30th 2026
Metabolic Health & Serious Mental IllnessSeptember 27th 2026
Advertisement
Advertisement
Trending on Psychiatric Times
1
ACNP Position Paper Lays Out Roadmap for Biomarker-Guided Psychiatric Drug Trials
2
Real-World Data Link LAI Risperidone to Fewer Emergency Visits in Schizophrenia, Improved Bipolar Treatment
3
From Side Effect to Target: Rethinking Metabolic Dysfunction in Psychiatry
4
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
5